Smoking reduction and temporary abstinence: New approaches for smoking cessation;Réduction de consommation tabagique et abstinence temporaire: De nouvelles approches pour l'arrêt du tabac

Journal des Maladies Vasculaires

Volumn 28, Issue 5, 2003, Pages 293-300

  Le Houezec, J ^a,b   Sawe U ^a  

^a Pharmacia and Upjohn   (Sweden)

^b R and D CHC   (France)

Author keywords

Nicotine; Smoking cessation; Tobacco smoking; Withdrawal

Indexed keywords

NICOTINE;

ABSTINENCE; ARTICLE; CIGARETTE SMOKING; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; MORBIDITY; MORTALITY; MOTIVATION; NICOTINE REPLACEMENT THERAPY; RISK FACTOR; SMOKING; SMOKING CESSATION; SMOKING HABIT; SYMPTOMATOLOGY; TOBACCO; WITHDRAWAL SYNDROME;

HUMANS; MOTIVATION; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO SMOKE POLLUTION;

EID: 0346494304     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. World Health Organization. World Health Report 1999, Chapter 5: Combating the Tobacco Epidemic. World Health Organization, Geneva, Switzerland (http://www.who.int/whr2001/2001/archives/1999/en/index.htm).
2. BOYLE P. European Cancer Experts recommendations for tobacco control. Ann Oncol, 1997; 8: 9-13.
3. GUILBERT P, BAUDIER F, GAUTIER A. Baromètre santé 2000. Vanves: CFES: 2001. Volume 2. Résultats. 480 p. (http://www.inpes.sante.fr/).
4. DUBOIS G. La réduction du risque tabagique. Direction générale de la santé. Paris; La Documentation française; 2002; 80 pages. (http://www.ladocumentationfrancaise.fr/brp/notices/ 024000149.html).
5. HUGHES JR. Dependence on and abuse of nicotine replacement: an update. In: Benowitz NL (ed): Nicotine safety and Toxicity, Oxford University Press, New York, 1998: pp 147-157.
6. ZELLER M. Reducing harm. SRNT Newsletter. 2000; 6: 1-5. (http://www.srnt.org/publications/newsltr/demoindex.htm).
7. HUGHES JR. Applying harm reduction to smoking. Tobacco Control, 1995; 4: S33-S38.
8. BURNS DM. Changes in cigarette-related disease risks and their implication for prevention and control. National Cancer Institute, NIH publication No.97-4213, Feb 1997. (http://cissecure.nci.nih.gov/ncipubs/).
9. SHIFFMAN S, MASON KM, HENNINGFIELD JE. Tobacco dependence treatments: review and prospectus. Annu Rev Public Health. 1998; 19: 335-58.
10. U.S. Department of Health and Human Services. The health consequences of smoking: nicotine addiction. A Report of the Surgeon General. US Government Printing Office, DHSS publication 88-8406, 1988. (http://profiles.nlm.nih.gov/NN/B/B/Z/D/).
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV): fourth edition. Washington, American Psychiatric Association. 1994.
12. th edn. WHO, Geneva, 1992.
13. LE HOUEZEC J. Pourquoi devient-on dépendant du tabac? La Revue du Praticien - Médecine générale, 2002; 16: 869-72.
14. SILAGY C, MANT D, FOWLER G, et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software. (http://www.update-software.com/abstracts/ab000146.htm).
15. DAUTZENBERG B. Le tabagisme passif. Direction générale de la santé. Paris; La documentation française; 2001; 200 pages. (http://www.ladocumentationfrancaise.fr/brp/notices/ 014000432.html).
16. World Health Organization Tobacco Free Initiative. International consultation on environmental tobacco smoke (ETS) and child health. WHO, Geneva, 1999 (WHO/NCD/TFI/99.10). (http://www.who.int/tobacco/health_impact/youth/ets/en/).
17. EISNER MD, SMITH AK, BLANC PD. Bartenders respiratory health after establishment of smoke-free bars and taverns. JAMA, 1998; 280: 1909-14.
18. GERLACH KK, SHOPLAND DR, HARTMAN AM, et al. Workplace smoking policies in the United States: results from a national survey of more than 100 000 workers. Tobacco Control, 1997; 6: 199-206.
19. HUGHES JR, CUMMINGS M, HYLAND A. Ability of smokers to reduce their smoking and its association with future smoking cessation. Addiction, 1999; 94: 109-14.
20. MCNEILL A, FOULDS J, BATES C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction, 2001; 96: 1757-68.
21. IRVIN JE, BRANDON TH. The increasing recalcitrance of smokers in clinical trials. Nicotine Tob Res, 2000; 2: 79-84.
22. PAOLETTI P, FORNAI E, MAGGIORELLI F, et al. Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch. Eur Respir J, 1996; 9: 643-51.
23. HAIRE-JOSHU D, GLASGOW RE, TIBBS TL. Smoking and diabetes. Diabetes Care, 1999; 22: 1887-98.
24. JIMENEZ-RUIZ C, KUNZE M, FAGERSTROM KO. Nicotine replacement: a new approach to reducing tobacco-related harm. Eur Resp J, 1998; 11: 473-9.
25. DICLEMENTE CC, PROCHASKA JO, FAIRHURST SK, et al. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol, 1991; 59: 295-304.
26. ETTER JF, PERNEGER TV, RONCHI A. Distributions of smokers by stage: international comparison and association with smoking prevalence. Prev Med, 1997; 26: 580-5.
27. BURTON SL, GITCHELL JG, SHIFFMAN S. Use of FDA-approved pharmacologic treatments for tobacco dependence. Morb Mortal Wkly Rep, 2000; 49: 665-8.
28. FAGERSTRÖM KO. Interventions for treatment-resistant smokers. Nicotine Tob Res, 1999; 1: S201-S205.
29. BOLLIGER CT, ZELLWEGER JP, DANIELSSON T, VAN BILJON X, ROBIDOU A, WESTIN A et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. Br Med J, 2000; 321: 329-33.
30. FAGERSTRÖM KO. From reduced smoking to quitting; improvements in COPD symptoms and lung function: a case report. Nicotine & Tobacco Research, 2001; 3: 93-4.
31. LE HOUEZEC J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int J Tuberc Lung Dis, 2003; 7: 811-9.
32. LE HOUEZEC J, BENOWITZ NL. Basic and clinical psychopharmacology of nicotine. Clin Chest Med, 1991; 12: 681-99.
33. POMERLEAU OF, FERTIG JB, SHANAHAN SD. Nicotine dependence in cigarette smoking: an empirically based multivariate model. Pharmacol Biochem Behav, 1983; 19: 291-9.
34. HATSUKAMI DK, HUGHES JR, PICKENS RW. Blood nicotine, smoke exposure and tobacco withdrawal symptoms. Addict Behav, 1985; 10: 413-7.
35. WEST RJ, RUSSELL MAH. Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms. Psychopharmacology, 1985; 87: 334-6.
36. PARROTT AC, GARNHAM NJ, WESNES K, PINCOCK C. Cigarette smoking and abstinence: comparative effects upon cognitive task performance and mood state over 24 hours. Human Psychopharmacology, 1996; 11: 391-400.
37. COHEN LM, COLLINS FL, BRITT DM. Effect of chewing gum on tobacco withdrawal. Addict Behav, 1997; 22: 769-73.
38. SNYDER FR, DAVIS FC, HENNINGFIELD JE. The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. Drug Alcohol Dep, 1989; 23: 259-66.
39. SOMMESE T, PATTERSON JC. Acute effects of cigarette smoking withdrawal: a review of the literature. Aviat Space Environ Med, 1995; 66: 164-7.
40. HERNING RI, JONES RT, BACHMAN J. EEG changes during tobacco withdrawal. Psychophysiology, 1983; 20: 507-12.
41. PICKWORTH WB, HERNING RI, HENNINGFIELD JE. Spontaneous EEG changes during tobacco abstinence and nicotine substitution in human volunteers. J Pharmacol Exp Ther, 1989; 251: 976-82.
42. WATERS AW, JARVIS MJ, SUTTON SR. Nicotine withdrawal and accident rates. Nature, 1998; 394: 137.
43. CHAPMAN S, HADDAD S, SINDHUSAKE D. Do work-place smoking bans cause smokers to smoke « harder »? Results from a naturalistic observational study. Addiction, 1997; 92: 607-10.
44. CHAPMAN S, BORLAND R, SCOLLO M, BROWNSON RC, DOMINELLO A, WOODWARD S. The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J Publ Health, 1999; 89: 1018-23.
45. FOULDS J. The pros and cons of harm reduction in relation to tobacco. Paper presented at WHO meeting on Regulation of Tobacco Dependence Treatment, Helsinki, October 18-19 1999. (http://www.euro.who.int/document/e74522.pdf).
46. MOLANDER L, LUNELL E, FAGERSTRÖM KO. Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study. Nicotine Tob Res, 2000; 2: 187-91.
47. FAGERSTRÖM KO, SCHNEIDER NC, LUNELL E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology, 1993; 11: 271-7.
48. CHEREK DR, BENNETT RH, GRABOWSKI J. Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum. Psychopharmacology, 1991; 104: 317-22.
49. HUGHES JR. Reduced smoking: an introduction and review of the evidence. Addiction, 2000; 95 (suppl 1): S3-S7.
50. KOZLOWSKI LT. Reduction of tobacco health hazards in continuing users: individual behavioral and public health approaches. J Subst Abuse, 1989; 1: 345-57.
51. FAGERSTRÖM KO, TEJDING R, WESTIN A, et al. Aiding reduction of smoking with nicotine replacement medications. Hope for the recalcitrant smoker? Tobacco Control, 1997; 6: 311-6.
52. KUNZE M. Harm reduction: the possible role of nicotine replacement. In: Bolliger CT, Fagerström KO (eds), The Tobacco Epidemic. Prog Respir Res, Basel, Karger, 1997: 190-8.
53. FORNAI E, DESIDERI M, PISTELLI F, CARROZZI L, PUNTONI R, AVINO S, et al. Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch. Monaldi Arch Chest Dis, 2001; 56: 5-10.
54. JOLICOEUR DG, AHLUWALIA JS, RICHTER KP, et al. The use of nicotine patches with minimal intervention. Prev Med, 2000; 30: 504-12.
55. LUOTO R, UUTELA A, PUSKA P. Occasional smoking increases total and cardiovascular mortality among young men. Nicotine Tob Res, 2000; 2: 133-9.
56. JACOBS DR, ADACHI H, MULDER I, et al. Cigarette smoking and mortality risk. Twenty-five year follow-up of the Seven Countries Study. Arch Int Med, 1999; 159: 733-40.
57. BENOWITZ NL, HALL SM, HERNING RI, et al. Smokers of low-yield cigarettes do not consume less nicotine. New Engl J Med, 1983; 309: 139-42.
58. WHITE P. Consumers and the changing cigarette. Presented at the WHO Conference on the Regulation of Tobacco Products, Helsinki, 18 October 1999. (http://www.who.dk/document/ e74524.pdf).
59. JARVIS MJ, BOREHAM R, PRIMATESTA P, FEYERABEND C, BRYANT A. Nicotine Yield From Machine-Smoked Cigarettes and Nicotine Intakes in Smokers: Evidence From a Representative Population Survey. J Natl Cancer Inst, 2001; 93: 134-8.
60. KOZLOWSKI LT, GOLDBERG ME, YOST BA, et al. Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking. Am J Prev Med, 1998; 15: 9-16.
61. STELLMAN SD, MUSCAT JE, THOMPSON S, et al. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer, 1997; 80: 382-8.
62. THUN MJ, LALLY CA, FLANNERY JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst, 1997; 89: 1580-6.
63. JARVIS MJ, TUNSTALL-PEDOE H, FEYERABEND C, et al. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health, 1987; 77: 1435-8.
64. LAW MR, MORRIS JK, WATT HC, et al. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer, 1997; 75: 1690-3.
65. RUTH KJ, NEATON JD. Evaluation of two biological markers of tobacco exposure. Prev Med, 1991; 20: 574-89.
66. BENOWITZ NL, JACOB PIII, AHIJEVYCH K, JARVIS MJ, HALL S, LE HOUEZEC J et al. Biochemical verification of tobacco use and cessation. Nicotine Tob Res, 2002; 4: 149-59.
67. JARVIS MJ, RUSSELL MAH, SALOOJEE Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J, 1980; 281: 484-5.
68. NETSCHER DT, WIGODA P, THORNBY J, et al. The hemodynamic and hematologic effects of cigarette smoking versus a nicotine patch. Plast Reconstr Surg, 1995; 96: 681-8.
69. BLANN AD, STELLE C, MCCOLLUM C, et al. The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost, 1997; 78: 1093-6.
70. LÚDVÍKSDÓTTIR D, BLÖNDAL T, FRANZON M, et al. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med, 1999; 246: 61-6.
71. KUULASMAA K, TUNSTALL-PEDOE H, DOBSON A, et al. for the WHO MONICA project. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet, 2000; 355: 675-87.
72. KANNEL WB, WOLF PA, CASTELLI WP, et al. Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA, 1987; 258: 1183-6.
73. KANNEL WB, ANDERSON K, WILSON PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA, 1992; 267: 1253-6.
74. DANESH J, COLLINS R, APPLEBY P, PETO R. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease. Meta-analyses of prospective studies. JAMA, 1998; 279: 1477-82.
75. HOLME I. An analysis of randomised trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation, 1990; 82: 1916-24.
76. SHEPHERD J, COBBE SM, FORD I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med, 1995; 333: 1301-7.
77. MEADE TW, IMESON J, STIRLING Y. Effects of changes in smoking and other characteristics of clotting factors and the risk of ischaemic heart disease. Lancet, 1987; 2: 986-7.
78. WALD NJ, WATT HC. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking-related diseases. Br Med J, 1997; 314: 1860-3.
79. ELIASSON B, HJALMARSON A, KRUSE E, WESTIN A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nic Tob Res, 2001; 3: 249-55.
80. HAUSTEIN KO, KRAUSE J, HAUSTEIN H, RASMUSSEN T, CORT N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med, 2002; 252: 130-9.
81. BOLLIGER CT, ZELLWEGER JP, DANIELSSON T, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine & Tobacco Research, 2002; 4: 433-9.
82. ETTER JF, LASZLO E, ZELLWEGER JP, PERROT C, PERNEGER TV. Nicotine replacement to reduce cigarette consumption in smokers who are not prepared to quit smoking: a randomized trial. J Clin Psychopharmacol, 2002; 22: 487-95.
83. WENNIKE P, DANIELSSON T, LANDFELDT B. Smoking reduction promotes smoking cessation. Results from a double blind, randomised, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction, 2003; 98: 1395-402.
84. ETTER JF, LE HOUEZEC J, LANDFELDT B. Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the internet. Addiction, 2003; 98: 941-50.